Navigation path

Pharmaceuticals - Union Register

  

Register of orphan medicinal products


GRANTED  

Product information

Hydrocinnamate-[Orn-Pro-dCha-Trp-Arg]acetate

EU orphan designation number: EU/3/15/1527   
Active ingredient: Hydrocinnamate-[Orn-Pro-dCha-Trp-Arg]acetate
Indication: Treatment of amyotrophic lateral sclerosis
Sponsor: PBS Regulatory Consulting Group Limited
5 E. Vows Walk, Kirkcaldy, KY1 1SQ Fife, United Kingdom

   Public summary of scientific opinion    

European Commission proceduresGoto top of the page

Close date procedure Procedure type EMEA number Decision summary publ decision docs annex
30/07/2015 Orphan designation EMA/OD/051/15 (2015)5436 of 28/07/2015